Section 7-3201 - DefinitionsFor the purposes of this chapter, the term:
(1) "DBH" means the Department of Behavioral Health.(2) "DHCF" means the Department of Health Care Finance.(3) "DISB" means the Department of Insurance, Securities, and Banking.(4) "DOC" means the Department of Corrections.(5) "DOH" means the Department of Health.(6) "Health care provider" means a physician, advance practice registered nurse, clinic, hospital, DBH-certified provider organizations, or neighborhood health center, licensed by the District.(7) "Health insurer" means any person that provides one or more health benefit plans or insurance in the District, including an insurer, a hospital and medical services corporation, a fraternal benefit society, a health maintenance organization, a multiple employer welfare arrangement, or any other person providing a plan of health insurance subject to the authority of the Commissioner of DISB.(8) "Hospital" means a facility that provides 24-hour inpatient care, including diagnostic, therapeutic, and other health-related services, for a variety of physical or mental conditions, and may, in addition, provide outpatient services, particularly emergency care.(9) "In-network health care provider" means the health care providers or health care facilities that have contracted with a health insurer to provide services to plan members for negotiated rates.(9A) [Not Funded.] "MPD" means the Metropolitan Police Department.(9B) [Not Funded.] "Opioid antagonist" shall have the same meaning as provided in section 3(i)(2) of An Act To relieve physicians of liability for negligent medical treatment at the scene of an accident in the District of Columbia, effective March 19, 2013 (D.C. Law 19-243; D.C. Official Code § 7-403(i)(2) ).(9C) [Not Funded.] "Opioid antagonist rescue kit" means a kit that contains: (A) An opioid antagonist;(B) Overdose educational materials that:(i) Conform to DOH or federal Substance Abuse and Mental Health Services Administration guidelines for opioid overdose education;(ii) Explain the signs and causes of an opioid overdose; and(iii) Instruct individuals when and how to administer an opioid antagonist in accordance with best medical practices; and(C) Up-to-date information on how and where to access opioid use disorder treatment in the District.(10) "Opioid use disorder" means a pattern of opioid use leading to clinically significant impairment or distress, as manifested by symptoms identified in the most recent publication of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.(11) "Opioid use disorder treatment medication" means all medications approved by the United States Food and Drug Administration for the treatment of opioid use disorders.(12) "Prescriber" means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs in the course of a professional practice.(13) "Telehealth" means the delivery of healthcare services through interactive audio, video, or other electronic media used for the purpose of diagnosis, consultation, or treatment; provided, that services delivered through audio-only telephones, electronic mail messages, or facsimile transmissions are not included.Amended by D.C. Law 23-182,§ 3, 68 DCR 003398, eff. 3/16/2021.Apr. 11, 2019, D.C. Law 22-288, § 101, 66 DCR 1656.